Provided by Tiger Trade Technology Pte. Ltd.

Candel Therapeutics, Inc.

13.07
0.0000
Post-market: 13.070.00000.00%16:10 EDT
Volume:895.01K
Turnover:11.61M
Market Cap:1.00B
PE:-9.08
High:13.22
Open:13.02
Low:12.63
Close:13.07
52wk High:14.00
52wk Low:4.35
Shares:76.52M
Float Shares:60.06M
Volume Ratio:0.78
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4390
EPS(LYR):-0.7210
ROE:-81.84%
ROA:-28.64%
PB:7.93
PE(LYR):-18.13

Loading ...

Mar 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2025

Major Issues Report

Form 8-K - Current report
Jan 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Major Issues Report

Form 8-K - Current report